Time trends in pathologic features of radical prostatectomy - Impact of family history

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 3, 2004, Pages 169-173

  Marotte, Jeffrey B ^a   Ferrari, Michelle K ^a   McNeal, John E ^a   Brooks, James D ^a   Presti Jr , Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Family history; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DENSITY; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

AGED; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 3242731356     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.04.003     Document Type: Article

References (34)

1. Woolf C.M. An investigation of the familial aspects of carcinoma of the prostate. Cancer. 13:1960;739-744
2. Carter B.S., Beaty T.H., Steinberg G.D., et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA. 89:1992;3367-3371
3. Steinberg G.D., Carter B.S., Beaty T.H., et al. Family history and the risk of prostate cancer. Prostate. 17:1990;337-347
4. Carter B.S., Bova G.S., Beaty T.H., et al. Hereditary prostate cancer epidemiologic and clinical features. J Urol. 150:1993;797-802
5. von Eschenbach A., Ho R., Murphy G.P., et al. American Cancer Society guidelines for the early detection of prostate cancer update, June 10, 1997. Cancer. 80:1997;1805-1807
6. Gronberg H., Isaacs S.D., Smith J.R., et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA. 278:1997;1251-1255
7. Kupelian P.A., Klein E.A., Witte J.S., et al. Familial prostate cancer a different disease? J Urol. 158:1997;2197-2201
8. Bratt O., Damber J.E., Emanuelsson M., et al. Hereditary prostate cancer clinical characteristics and survival. J Urol. 167:2002;2423-2426
9. Gronberg H., Damber L., Tavelin B., et al. No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol. 82:1998;564-567
10. Valeri A., Azzouzi R., Drelon E., et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate. 45:2000;66-71
11. Kupelian P.A., Kupelian V.A., Witte J.S., et al. Family history of prostate cancer in patients with localized prostate cancer an independent predictor of treatment outcome. J Clin Oncol. 15:1997;1478-1480
12. Rohrmann S., Roberts W.W., Walsh P.C., et al. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate. 55:2003;140-146
13. Cotter M.P., Gern R.W., Ho G.Y., et al. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate. 50:2002;216-221
14. Bastacky S.I., Wojno K.J., Walsh P.C., et al. Pathological features of hereditary prostate cancer. J Urol. 153:1995;987-992
15. Bratt O., Kristoffersson U., Olsson H., et al. Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor. Eur Urol. 34:1998;19-24
16. Keetch D.W., Humphrey P.A., Smith D.S., et al. Clinical and pathological features of hereditary prostate cancer. J Urol. 155:1996;1841-1843
17. Kotsis S.V., Spencer S.L., Peyser P.A., et al. Early onset prostate cancer predictors of clinical grade. J Urol. 167:2002;1659-1663
18. Nippon S., Masuda H., Sato J., et al. An analysis of familial prostate cancer. Nippon Hinyokika Gakkai Zasshi. 86:1995;1483
19. Stamey T., Raimondo M., Yemoto C.M., et al. Effect of aging on morphologic and clinical predictors of prostate cancer progression. Prostate. 2:2000;157-161
20. Presti J.C. Jr, O'Dowd G.J., Miller M.C., et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates results of a community multi-practice study. J Urol. 169:2003;125-129
21. Schmid H.P., McNeal J.E. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol. 16:1992;184-191
22. Cerhan J.R., Parker A.S., Putnam S.D., et al. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev. 8:1999;53-60
23. Aprikian A.G., Bazinet M., Plante M., et al. Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J Urol. 154:1995;404-406
24. Bova G.S., Partin A.W., Isaacs S.D., et al. Biological aggressiveness of hereditary prostate cancer long-term evaluation following radical prostatectomy. J Urol. 160:1998;660-663
25. Gann P.H., Hennekens C.H., Stampfer M.J. Evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 273:1995;289-294
26. Draisma G., Boer S., Otto S.J., et al. Lead times and over detection due to prostate-specific antigen screening estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 95:2003;868-878
27. Arar N., Thompson I., Sarosdy M., et al. Risk perceptions among patients and their relatives regarding prostate cancer and its heredity. Prostate Cancer Prostatic Dis. 3:2000;176-185
28. Miller S.M., Diefenbach M.A., Kruus L.K., et al. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med. 24:2001;247-258
29. Steele C.B., Miller D.S., Maylahn C., et al. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health. 90:2000;1595-1600
30. Cormier L., Reid K., Kwan L., et al. Screening behavior in brothers and sons of men with prostate cancer. J Urol. 169:2003;1715-1719
31. Zhu K., McKnight B., Stergachis A., et al. Comparison of self-report data and medical records data results from a case-control study on prostate cancer. Int J Epidemiol. 28:1999;409-417
32. King T.M., Tong L., Pack R.J., et al. Accuracy of family history of cancer as reported by men with prostate cancer. Urology. 59:2002;546-550
33. Ziogas A., Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med. 24:2003;190-198
34. Bratt O., Kristoffersson U., Lundgren R., et al. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer. 35:1999;272-277